Clinical trial
Duloxetine vs Placebo in the Treatment of General Anxiety
NCT00475969 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00475969 |
|---|---|
| Title | Duloxetine vs Placebo in the Treatment of General Anxiety |
| Official title | Duloxetine Hydrochloride Once Daily Compared With Placebo in the Treatment of Generalized Anxiety Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Boehringer Ingelheim Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anxiety |
| Intervention type | Drug |
| Interventions | duloxetine, placebo |
| Enrollment | 327 |
| Start date | Aug 1, 2004 |
| Completion | Jun 1, 2005 |
| First posted | May 21, 2007 |
| Last update posted | May 21, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: